Lyra Therapeutics, Inc. - stock earnings
LYRA Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -15.7 million USD | 544000 USD |
| 2023Q2 | -15.6 million USD | 458000 USD |
| 2023Q1 | -16.3 million USD | 410000 USD |
| 2022Q4 | -14.2 million USD | 11000 USD |
| 2022Q3 | -14.7 million USD | 359000 USD |
| 2022Q2 | -14.4 million USD | 407000 USD |
| 2022Q1 | -7.0 million USD | 5.4 million USD |
| 2021Q4 | -13.3 million USD | 271000 USD |
| 2021Q3 | -11.1 million USD | 14000 USD |
| 2021Q2 | -11.0 million USD | ? USD |
| 2021Q1 | -7.8 million USD | ? USD |
| 2020Q4 | -7.0 million USD | ? USD |
| 2020Q3 | -6.3 million USD | ? USD |
| 2020Q2 | -4.5 million USD | ? USD |
| 2020Q1 | -4.2 million USD | ? USD |
| 2019Q4 | -4.4 million USD | ? USD |
| 2019Q3 | -4.2 million USD | ? USD |
| 2019Q2 | -4.2 million USD | ? USD |
| 2019Q1 | -3.6 million USD | ? USD |
LYRA Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -61.8 million USD | 1.4 million USD |
| 2022 | -55.3 million USD | 1.4 million USD |
| 2021 | -42.4 million USD | 285000 USD |
| 2020 | -22.0 million USD | ? USD |
| 2019 | -16.1 million USD | ? USD |
| 2018 | -6.0 million USD | 1.2 million USD |
LYRA
Price: $4.03
52 week price:
Earnings Per Share: -1.26 USD
P/E Ratio: -3.34
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 10913
Market Capitalization: 299.9 million